Trials in New York, New York
Here are the top 10 medical studies for prostate cancer in New York, New York
Popular Filters
Phase 3 Trials
PARP Inhibitor
Niraparib + Abiraterone Acetate + Prednisone for Metastatic Prostate Cancer
Recruiting1 awardPhase 3
Hamilton, Ontario
This trial will compare the effect of adding niraparib to abiraterone acetate plus prednisone, versus abiraterone acetate plus prednisone and placebo, in men with metastatic castration-resistant prostate cancer.
PARP Inhibitor
Olaparib + Abiraterone for Prostate Cancer
Recruiting1 awardPhase 3
Toronto, Ontario
This trial is testing the combination of olaparib and abiraterone versus placebo and abiraterone to see if it is more effective and has fewer side effects in patients with mCRPC who have not received prior chemotherapy or NHAs.
Hormone Therapy
Standard Therapy + Surgery/Radiation for Prostate Cancer
Recruiting2 awardsPhase 3
Newark, Delaware
This trial is testing whether adding surgery or radiation therapy to standard treatment for prostate cancer that has spread to other parts of the body lowers the chance of the cancer growing or spreading.
Checkpoint Inhibitor
Pembrolizumab + ADT for Prostate Cancer
Recruiting2 awardsPhase 3
St. Catharines, Ontario
This trial will test whether a combination of drugs is better than placebo at extending radiographic progression-free survival and overall survival for men with metastatic hormone-sensitive prostate cancer.
Radiation
Darolutamide + Standard Therapy for Prostate Cancer
Recruiting1 awardPhase 3
Toronto, Ontario
This trial is testing darolutamide, a new drug added to standard hormone therapy, in men with high-risk localized prostate cancer undergoing radiation. The goal is to see if this combination can better prevent the cancer from coming back and spreading compared to current treatments. Darolutamide works by blocking male hormones that help cancer grow, potentially reducing death rates from prostate cancer.
Trials With No Placebo
Behavioral Intervention
Nutrition and Exercise Advice for Prostate Cancer
Recruiting1 award10 criteria
Buffalo, New York
This trial looks at whether giving nutrition and exercise advice to prostate cancer patients who are on androgen deprivation therapy can help to reduce obese frailty and change the levels of myokines in blood.
Monoclonal Antibodies
Lorigerlimab for Advanced Solid Tumors
Recruiting1 awardPhase 1
Erie, Pennsylvania
This trial is testing a new drug, lorigerlimab, to see if it is safe and effective in treating patients with advanced solid tumors. The trial will first determine the maximum tolerated dose of the drug, and then expand to test its efficacy in specific tumor types.
Hormone Therapy
Standard Therapy + Surgery/Radiation for Prostate Cancer
Recruiting2 awardsPhase 3
Newark, Delaware
This trial is testing whether adding surgery or radiation therapy to standard treatment for prostate cancer that has spread to other parts of the body lowers the chance of the cancer growing or spreading.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.